CD8A and ovarian cancer: Intriguingly, evidence from one recent ovarian cancer study by Wu et al. indicates that levels and production of IFN-γ by peripheral blood CD4 and CD8 effector T cells may temporarily increase at the start of chemotherapy while CD4+CD25+ Treg levels temporarily decrease [28], suggesting effector function increases after the first round of chemotherapy.